Rhelion Life Sciences Corp (RHEL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 785 | 622 | 622 | 486 | 595 |
| Cost of Goods | 496 | 490 | 389 | 329 | 499 |
| Gross Profit | 289 | 132 | 233 | 157 | 96 |
| Operating Expenses | 1,689 | 3,441 | 1,281 | 1,827 | 3,578 |
| Operating Income | -1,400 | -3,309 | -1,048 | -1,670 | -3,482 |
| Interest Expense | 4 | 2 | 18 | 8 | 22 |
| Other Income | -186 | -5,126 | -140 | -164 | 48 |
| Pre-tax Income | -1,590 | -8,437 | -1,207 | -1,842 | -3,456 |
| Income Tax | -55 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -1,535 | -8,190 | -1,207 | -1,842 | -3,456 |
| Minority Interests | 32 | 302 | 26 | N/A | N/A |
| Net Income | $-1,503 | $-7,889 | $-1,180 | $-1,842 | $-3,456 |
| EPS Basic Total Ops | 0.00 | -0.02 | 0.00 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | 0.00 | -0.02 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Total Ops | 0.00 | -0.02 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | -0.02 | 0.00 | -0.01 | -0.01 |
| EBITDA(a) | $-1,442 | $-8,243 | $-1,070 | $-1,720 | $-3,334 |